BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29065399)

  • 1. Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes.
    Laliscia C; Gadducci A; Fabrini MG; Barcellini A; Guerrieri ME; Parietti E; Ursino S; Morganti R; Cafaro I; Paiar F
    Oncol Res Treat; 2017; 40(11):697-701. PubMed ID: 29065399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant External-beam Irradiation and Chemotherapy Followed by High-dose Rate Brachytherapy Boost in the Treatment of Squamous Cell Carcinoma of the Vagina: A Single-Center Retrospective Study.
    Laliscia C; Fabrini MG; Delishaj D; Coraggio G; Morganti R; Tana R; Paiar F; Gadducci A
    Anticancer Res; 2016 Apr; 36(4):1885-9. PubMed ID: 27069175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
    Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
    Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of vaginal squamous cell carcinoma of patients treated with radiation therapy: a series of 37 patients from a single expert center.
    Romano E; Janati S; Monnier L; Darai É; Bendifallah S; Schlienger M; Touboul E; Rivin Del Campo E; Huguet F
    Clin Transl Oncol; 2020 Aug; 22(8):1345-1354. PubMed ID: 31873914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
    Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
    Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
    Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
    Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
    Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
    Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
    Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive radiation therapy for invasive carcinoma of the vagina: impact of high-dose rate intracavitary brachytherapy.
    Nonaka T; Nakayama Y; Mizoguchi N; Onose R; Kato H; Nakayama H
    Int J Clin Oncol; 2013 Apr; 18(2):314-20. PubMed ID: 22310898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
    Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
    Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
    Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
    Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
    Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
    Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
    Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes.
    Hiniker SM; Roux A; Murphy JD; Harris JP; Tran PT; Kapp DS; Kidd EA
    Gynecol Oncol; 2013 Nov; 131(2):380-5. PubMed ID: 23954572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.